ALX Oncology Holdings Inc.

Filed a patent for "sirp-alpha variant constructs and uses thereof" on Thu, January 9, 2025

Filed a patent for "exatecan derivatives and antibody-drug conjugates thereof" on Mon, November 6, 2023

Filed a patent for "constructs having a sirp-alpha domain or variant thereof" on Thu, March 16, 2023

Filed a patent for "constructs having a sirp-alpha domain or variant thereof" on Thu, October 17, 2024

Filed a patent for "activatable antibodies and methods of use thereof" on Thu, October 3, 2024

Filed a patent for "sirp-alpha variant constructs and uses thereof" on Thu, October 26, 2023

Filed a patent for "exatecan derivatives and antibody-drug conjugates thereof" on Fri, November 4, 2022

Filed a patent for "combination therapies for treating cancer" on Thu, July 13, 2023

Filed a patent for "combination therapies for treating urothelial carcinoma" on Thu, January 11, 2024

Filed a patent for "combination therapies for treating cancer" on Thu, March 7, 2024

Filed a patent for "methods of treating cancer" on Thu, April 25, 2024

Filed a patent for "methods of treating cancer" on Thu, August 4, 2022

Filed a patent for "combination therapies for treating urothelial carcinoma" on Wed, June 1, 2022